Celebrating 30 Years of Innovation Excellence with Advanced OEM Solutions for Healthcare Summary: Successful Showcase: ADLINK's latest AI-driven medical solutions attracted strong industry interest at ...

Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

Hims & Hers (NYSE: HIMS) stock is down 50% from its peak earlier this year, but the drop in shares hasn't been driven by deteriorating operations. In fact, the company is growing as fast as ever. In ...

Walgreens was too big to fail entirely–but made too many mistakes and remained in too many dying segments. The Gimlet Eye credits Walgreens for making a good deal with private equity firm Sycamore ...

By Brian Brown, president and partner at food marketing agency Ingredient  For those living on the West Coast of North ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents.

HIMSS outlines priorities; Memorial Sloan Kettering taps Abridge; UpToDate integrates with new Microsoft Dragon Copilot ...

Healthcare leaders may still be looking for ROI and sustainability, but they know AI is here to stay, and they want to make sure they’re on the right path.

Hims & Hers reported its Q4 earnings this week. The company is growing quickly but faces a potential legal threat to its ...

And that’s focusing attention on what’s truly important. And what is truly important? One absolute area of focus is ...